Juan Pablo Santino
YOU?
Author Swipe
View article: Characterization of Screening Strategies for Lynch Syndrome in Latin America
Characterization of Screening Strategies for Lynch Syndrome in Latin America Open
View article: Mesenteric root pseudocyst: finding in an asymptomatic patient—a case report
Mesenteric root pseudocyst: finding in an asymptomatic patient—a case report Open
Background Mesenteric cysts are one of the rarest abdominal tumor masses, representing a little-studied pathology. In turn, the variability and non-specificity of clinical manifestations make diagnosis difficult, as it can be reached by im…
View article: International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy
International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy Open
PURPOSE No biomarker capable of improving selection and monitoring of patients with rectal cancer managed by watch-and-wait (W&W) strategy is currently available. Prognostic performance of the Immunoscore biopsy (IS B ) was recently sugges…
View article: Adenoma de las glándulas de Brunner: Causa infrecuente de hemorragia digestiva alta. Reporte de caso
Adenoma de las glándulas de Brunner: Causa infrecuente de hemorragia digestiva alta. Reporte de caso Open
Reportamos el caso de un paciente masculino de 56 años de edad que ingresa por un cuadro de melena. Se le realiza una videoendoscopía alta de urgencia en la que se observa una lesión polipoidea subpediculada de superficie congestiva, de ap…
View article: Data from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
Data from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy Open
Purpose:No biomarker to personalize treatment in locally advanced rectal cancer (LARC) is currently available. We assessed in LARC whether a diagnostic biopsy-adapted immunoscore (ISB) could predict response to neoadjuvant treat…
View article: Supplementary Tables from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
Supplementary Tables from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy Open
Supplementary Tables
View article: Supplementary Figures from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
Supplementary Figures from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy Open
Supplementary Figures
View article: Supplementary Figures from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
Supplementary Figures from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy Open
Supplementary Figures
View article: Supplementary Tables from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
Supplementary Tables from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy Open
Supplementary Tables
View article: Data from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
Data from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy Open
Purpose:No biomarker to personalize treatment in locally advanced rectal cancer (LARC) is currently available. We assessed in LARC whether a diagnostic biopsy-adapted immunoscore (ISB) could predict response to neoadjuvant treat…
View article: Adenocarcinoma de la unión gastroesofágica metastásico con déficit de expresión de proteínas de reparación del ADN
Adenocarcinoma de la unión gastroesofágica metastásico con déficit de expresión de proteínas de reparación del ADN Open
Se presenta a continuación el caso clínico de una mujer de 69 años con diagnóstico de adenocarcinoma de la unión gastroesofágica localmente avanzado, que realizó tratamiento con esquema CROSS y posterior esofagectomía. Presentó recaída en …
View article: Biopsia de linfadenopatía retroperitoneal guiada por imágenes con abordaje trans-vertebral
Biopsia de linfadenopatía retroperitoneal guiada por imágenes con abordaje trans-vertebral Open
Introducción: La biopsia trans ósea permite el estudio de lesiones que presentan accesos convencionales bloqueados por otras estructuras, como órganos vitales. Su uso evita procedimientos de mayor complejidad.
Objetivo: Reportar un caso c…
View article: Endometriosis intestinal, una causa de suboclusión intestinal poco sospechada. Serie de casos
Endometriosis intestinal, una causa de suboclusión intestinal poco sospechada. Serie de casos Open
Endometriosis is defined as the presence of endometrial glands in extrauterine sites. Intestinal deep infiltrating endometriosis is considered when the endometriotic lesion is located more than 5 mm below the peritoneum. Intestinal obstruc…
View article: A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy Open
Purpose: No biomarker to personalize treatment in locally advanced rectal cancer (LARC) is currently available. We assessed in LARC whether a diagnostic biopsy-adapted immunoscore (ISB) could predict response to neoadjuvant treatment (nT) …
View article: Carcinoma hepatoide gástrico
Carcinoma hepatoide gástrico Open
El adenocarcinoma hepatoide gástrico es un tumor maligno de baja incidencia, se describen asociados a aumento de alfa-fetoproteína y tienen pobre pronóstico.
Se presenta el caso de un paciente de 44 años que en un contexto de síndro…
View article: Síndrome de Lynch: impacto de la caracterización de familias en base a estudios genéticos
Síndrome de Lynch: impacto de la caracterización de familias en base a estudios genéticos Open
El objetivo de este trabajo fue caracterizar demográfica y molecularmente las familias con diagnóstico de síndrome de Lynch en base a estudios genéticos. Se utilizó la base prospectiva del Registro de Epidemiología Molecular de Cánce…
View article: Locally advanced cervical squamous cell carcinoma (CSCC): Impact of the FDG PET/CT in the primary staging
Locally advanced cervical squamous cell carcinoma (CSCC): Impact of the FDG PET/CT in the primary staging Open